Holtug Lars
Director at ASND
- Sold, on record
- $62k
- Dollars the filings state
- Form 4 sales
- 1
- Latest Sep 2, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ASNDAscendis Pharma A/SDirector
Sales by reason
0
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice ASNDNoticeMar 1, 2024 2024
Filed to sell 653 shares ($96k)
Holtug Lars, Director, NON EXECUTIVE DIRECTOR
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice ASNDNoticeMar 4, 2025 +368 days
Filed to sell 1,470 shares ($224k)
Holtug Lars, Director
10b5-1 planFirst sale on recordFiling
- 3 Form 144 notice ASNDNoticeMar 2, 2026 +363 days
Filed to sell 2,100 shares ($508k)
Holtug Lars, Director
10b5-1 planFirst sale on recordFiling
- 4 Form 144 notice ASNDNoticeSep 2, 2026 +184 days
Filed to sell 236 shares ($62k)
Holtug Lars, Director
No 10b5-1 planFirst sale on recordFiling
- 5 Form 4 sale ASNDNo planSep 2, 2026 same day
Sold 236 shares at $264.13 ($62k)
Holtug Lars, Director
No 10b5-1 planSold 5.6% of holdings ($1.1M position)4,000 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Sep 3, 2026 | ASND | Director | Form 4 sale | 236 | $62k | 5.6% | No plan | SEC |
| Sep 2, 2026 | Sep 2, 2026 | ASND | Director | Form 144 notice | 236 | $62k | Notice | SEC | |
| Mar 2, 2026 | Mar 2, 2026 | ASND | Director | Form 144 notice | 2,100 | $508k | Notice | SEC | |
| Mar 4, 2025 | Mar 4, 2025 | ASND | Director | Form 144 notice | 1,470 | $224k | Notice | SEC | |
| Mar 1, 2024 | Mar 1, 2024 | ASND | Director, NON EXECUTIVE DIRECTOR | Form 144 notice | 653 | $96k | Notice | SEC |